ORG Partners LLC cut its holdings in shares of Elevance Health, Inc. (NYSE:ELV – Free Report) by 31.1% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 82 shares of the company’s stock after selling 37 shares during the period. ORG Partners LLC’s holdings in Elevance Health were worth $30,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors have also recently modified their holdings of the business. Iridian Asset Management LLC CT lifted its position in Elevance Health by 10.7% during the third quarter. Iridian Asset Management LLC CT now owns 39,154 shares of the company’s stock valued at $20,360,000 after acquiring an additional 3,786 shares during the last quarter. International Assets Investment Management LLC lifted its position in Elevance Health by 85,533.1% during the third quarter. International Assets Investment Management LLC now owns 532,638 shares of the company’s stock valued at $276,972,000 after acquiring an additional 532,016 shares during the last quarter. Benjamin Edwards Inc. lifted its position in Elevance Health by 1,711.9% during the third quarter. Benjamin Edwards Inc. now owns 53,559 shares of the company’s stock valued at $27,858,000 after acquiring an additional 50,603 shares during the last quarter. Diversified Trust Co lifted its position in Elevance Health by 13.7% during the fourth quarter. Diversified Trust Co now owns 22,576 shares of the company’s stock valued at $8,328,000 after acquiring an additional 2,725 shares during the last quarter. Finally, BNP PARIBAS ASSET MANAGEMENT Holding S.A. lifted its position in Elevance Health by 5.0% during the third quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A. now owns 209,859 shares of the company’s stock valued at $109,127,000 after acquiring an additional 9,916 shares during the last quarter. 89.24% of the stock is currently owned by institutional investors.
Insider Activity at Elevance Health
In other news, EVP Charles Morgan Kendrick, Jr. sold 7,417 shares of Elevance Health stock in a transaction dated Friday, October 18th. The shares were sold at an average price of $432.14, for a total value of $3,205,182.38. Following the sale, the executive vice president now owns 8,423 shares in the company, valued at $3,639,915.22. This trade represents a 46.82 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 0.35% of the stock is owned by company insiders.
Analyst Ratings Changes
Read Our Latest Research Report on Elevance Health
Elevance Health Stock Down 0.5 %
ELV stock opened at $381.41 on Monday. The firm has a market cap of $88.46 billion, a PE ratio of 13.90, a P/E/G ratio of 1.15 and a beta of 0.84. The company has a debt-to-equity ratio of 0.56, a quick ratio of 1.50 and a current ratio of 1.50. The firm’s fifty day moving average is $391.39 and its 200 day moving average is $471.32. Elevance Health, Inc. has a one year low of $362.21 and a one year high of $567.26.
Elevance Health (NYSE:ELV – Get Free Report) last released its quarterly earnings results on Thursday, October 17th. The company reported $8.37 EPS for the quarter, missing the consensus estimate of $9.66 by ($1.29). The firm had revenue of $44.72 billion for the quarter, compared to analyst estimates of $43.47 billion. Elevance Health had a net margin of 3.68% and a return on equity of 19.56%. The firm’s quarterly revenue was up 5.3% compared to the same quarter last year. During the same quarter in the prior year, the business posted $8.99 EPS. On average, research analysts forecast that Elevance Health, Inc. will post 32.96 EPS for the current year.
Elevance Health Announces Dividend
The company also recently declared a quarterly dividend, which was paid on Friday, December 20th. Investors of record on Thursday, December 5th were given a dividend of $1.63 per share. The ex-dividend date of this dividend was Thursday, December 5th. This represents a $6.52 annualized dividend and a yield of 1.71%. Elevance Health’s dividend payout ratio is presently 23.77%.
Elevance Health Profile
Elevance Health, Inc, together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits.
Featured Articles
- Five stocks we like better than Elevance Health
- Breakout Stocks: What They Are and How to Identify Them
- ServiceTitan Made Waves in Its IPO, But Is the Stock a Buy?
- How to Invest in Biotech Stocks
- Netflix: Is This the Perfect Time to Buy a Streaming Powerhouse?
- 3 Monster Growth Stocks to Buy Now
- Goldman Sachs Unveils 3 Massive Opportunities for 2025 Investors
Want to see what other hedge funds are holding ELV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Elevance Health, Inc. (NYSE:ELV – Free Report).
Receive News & Ratings for Elevance Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elevance Health and related companies with MarketBeat.com's FREE daily email newsletter.